SPAGO.ST

Research by ALPHA

Author: Alpha
  • 0.20 +2.05% (02/04/2025)
  • MONITOR 

Spago Nanomedical is an early stage Biotech startup developing nano-materials as contrast fluid for MR scans to improve detection of cancer. At the current Phase I/IIa the company is pre-revenue and a high-risk investment.

04/03/2025| Analyses:0
0